Name | A-893 |
---|---|
Synonyms |
N-Cyclohexyl-N-[2-(3,4-dichlorophenyl)ethyl]-N-(2-{[(2R)-2-hydroxy-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-8-yl)ethyl]amino}ethyl)-β-alaninamide
Propanamide, N-cyclohexyl-3-[[2-(3,4-dichlorophenyl)ethyl]amino]-N-[2-[[(2R)-2-(3,4-dihydro-3-oxo-2H-1,4-benzoxazin-8-yl)-2-hydroxyethyl]amino]ethyl]- |
Description | A-893 is a cell-active inhibitor of Methyltransferase SMYD2, with an IC50 of 2.8 nM. |
---|---|
Related Catalog | |
Target |
IC50: 2.8 nM (SMYD2)[1]. |
In Vitro | The ratio of p53K370me1 to overall p53 levels is reduced, as expected, by treatment with either A-893 or AZ505. While this unexpectedly depicts a more robust response with AZ505, further dissection of the data provides clarity into the origin of this. While overall p53 levels are unaffected by A-893, a surprising >3-fold increase is observed with AZ505. Analysis of p53K370me1 levels reveals that inhibitor A-893 exhibited 42% reduction in the methyl mark, while AZ-505 is slightly less effective at 28% reduction[1]. |
Cell Assay | Human A549 lung carcinoma cells are chosen due to their high SMYD2 expression levels and wild-type p53 status. After 18 h of treatment with 10 μM of compound (e.g. A-893), changes in p53K370me1 are measured along with changes to overall p53 levels[1]. |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 790.6±60.0 °C at 760 mmHg |
Molecular Formula | C29H38Cl2N4O4 |
Molecular Weight | 577.542 |
Flash Point | 431.9±32.9 °C |
Exact Mass | 576.226990 |
LogP | 3.13 |
Vapour Pressure | 0.0±2.9 mmHg at 25°C |
Index of Refraction | 1.623 |